AMBS - Interesting CEO presentation Tuesday on MANF ability to treat parkinsons(early trial results revealed) and other applications in alzheimers and 40% of heart attacks. That is followed by the founder of Amgen(Dr Rubenfield) discussion of applications. AMBS recently won a major challenge lawsuit that gives them very broad patent rights in that potential drug/treatment category. Possible big Pharma interest here?
I have a position at a lower price point and watching the run here. There is alot of arguing back and forth on the MB about the value of the company. This might be one to watch.